INS and major depressive disorder: In addition, when a “next generation antidepressant” L-acetylcartinine (LAC) is administered to a genetic rat model of depression (Flinders Sensitive Line), the treatment reduces insulin and glucose levels, suggesting an insulin resistant state that responds to LAC.